<?xml version="1.0" encoding="utf-8"?>
<XML>
    <JOURNAL>
        <YEAR>2026</YEAR>
        <VOL>17</VOL>
        <NO>1</NO>
        <MOSALSAL></MOSALSAL>
        <PAGE_NO>2</PAGE_NO>
        <ARTICLES>
            <ARTICLE>
                <Language_ID>1</Language_ID>
                <TitleE>Silent Casualties of War: Stress-Driven Cardiotoxicity in Patients with Cancer Receiving Chemotherapy</TitleE>
                <URL>https://brieflands.com/journals/mca/articles/169637</URL>
                <DOI>10.69107/mca-169637</DOI>
                <DOR></DOR>
                <ABSTRACTS>
                    <ABSTRACT>
                        <Language_ID>1</Language_ID>
                        <CONTENT>This article has no abstract regards to the type of article</CONTENT>
                    </ABSTRACT>
                </ABSTRACTS>
                <PAGES>
                    <PAGE>
                        <FPAGE>1</FPAGE>
                        <TPAGE>2</TPAGE>
                    </PAGE>
                </PAGES>
                <AUTHORS>
                    <AUTHOR>
                        <NameE>Azin</NameE>
                        <MidNameE></MidNameE>
                        <FamilyE>Alizadehasl</FamilyE>
                        <Organizations>
                            <Organization>Cardio-Oncology Research Center, Rajaie Cardiovascular Institute, Tehran, Iran</Organization>
                        </Organizations>
                        <Countries>
                            <Country>Iran</Country>
                        </Countries>
                        <EMAILS>
                            <Email>alizadeasl@gmail.com</Email>
                        </EMAILS>
                    </AUTHOR>
                    <AUTHOR>
                        <NameE>Batoul</NameE>
                        <MidNameE></MidNameE>
                        <FamilyE>Naghavi</FamilyE>
                        <Organizations>
                            <Organization>Cardio-Oncology Research Center, Rajaie Cardiovascular Institute, Tehran, Iran</Organization>
                        </Organizations>
                        <Countries>
                            <Country>Iran</Country>
                        </Countries>
                        <EMAILS>
                            <Email>naghavirhc@gmail.com</Email>
                        </EMAILS>
                    </AUTHOR>
                    <AUTHOR>
                        <NameE>Armita</NameE>
                        <MidNameE></MidNameE>
                        <FamilyE>Azarfarin</FamilyE>
                        <Organizations>
                            <Organization>Cardio-Oncology Research Center, Rajaie Cardiovascular Institute, Tehran, Iran</Organization>
                        </Organizations>
                        <Countries>
                            <Country>Iran</Country>
                        </Countries>
                        <EMAILS>
                            <Email>armiazarfarin@gmail.com</Email>
                        </EMAILS>
                    </AUTHOR>
                </AUTHORS>
                <KEYWORDS>
                    <KEYWORD>
                        <KeyText>No Keyword</KeyText>
                    </KEYWORD>
                </KEYWORDS>
                <PDFFileName>1.pdf</PDFFileName>
                <REFRENCES>
                    <REFRENCE>
                        <REF>[0]Rakisheva A, Farmakis D, Attanasio A, Genis AB, Cohen-Solal A, Gulati G, et al.Prevention of cancer therapy-related cardiac dysfunction and heart failure in cancer patients and survivors: a clinical consensus statement of the Heart Failure Association, the European Association of Preventive Cardiology of the ESC, and the ESC Council of Cardio-Oncology. Eur J Heart Fail. 2025;27(11):2084-2099. [PubMed ID: 40679941]. doi: 10.1002/ejhf.3753.##[1]Ameri P, Canepa M, Anker MS, Belenkov Y, Bergler-Klein J, Cohen-Solal A, et al.Heart Failure Association Cardio-Oncology Study Group of the European Society of Cardiology. Cancer diagnosis in patients with heart failure: Epidemiology clinical implications and gaps in knowledge. Eur J Heart Fail. 2018;20(5):879-887. [PubMed ID: 29464808]. doi: 10.1002/ejhf.1165.##[2]Maleki S, Esmaeili Z, Seighali N, Shafiee A, Namin SM, Zavareh MAT, et al.Cardiac adverse events after chimeric antigen receptor T-cell therapies: an updated systematic review and meta-analysis. Cardiooncology. 2024;10(1). 52. [PubMed ID: 39164789]. [PubMed Central ID: PMC11334556]. doi: 10.1186/s40959-024-00252-y.##[3]Alizadehasl A, Ghadimi N, Kaveh S, Maleki M, Ghavamzadeh A, Noohi F, et al.Prevention of anthracycline-induced cardiotoxicity: a systematic review and network meta-analysis. Int J Clin Pharm. 2021;43(1):25-34. [PubMed ID: 32910372]. doi: 10.1007/s11096-020-01146-6.##[4]Katz AR, Huntwork MP, Kolls JK, Hewes JL, Ellsworth CR, Clark RDE, et al.Impact of psychological stressors on natural killer cell function: a comprehensive analysis based on stressor type, duration, intensity, and species. Physiol Behav. 2025;288. 114734. [PubMed ID: 39547436]. doi: 10.1016/j.physbeh.2024.114734.##[5]Liu Z, Lei M, Bai Y.Chronic stress mediates inflammatory cytokine alterations and its role in tumorigenesis. J Inflamm Res. 2025;18:1067-1090. [PubMed ID: 39871957]. [PubMed Central ID: PMC11769853]. doi: 10.2147/JIR.S485159.##</REF>
                    </REFRENCE>
                </REFRENCES>
            </ARTICLE>
        </ARTICLES>
    </JOURNAL>
</XML>